Kochevar to retire from Colorado Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Mark Kochevar, associate director for administration and finance at the University of Colorado Cancer Center retired on May 31, 2018, after a career of 41 years in cancer research administration. Kochevar began his career as the assistant administrative officer for the Clinical Oncology Program in the NCI’s Division of Cancer Treatment in May 1977.

YOU MAY BE INTERESTED IN

 For nearly 30 years, the American Cancer Society’s prostate cancer screening guidelines have advised men to discuss prostate-specific antigen, or PSA, testing with a clinician and weigh potential benefits and harms, rather than treat screening as an unquestioned routine. This “informed decision-making” recommendation was consistent with guidelines from all major professional organizations in the United States, Canada, and Europe. 
For patients with an HPV-related form of throat cancer, treatment is often highly effective, with cure rates as high as 90%, depending on the disease stage. Now, researchers are investigating whether some patients can safely avoid additional treatment while maintaining excellent cancer outcomes.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login